JP, G., P, G., A, P., L, G., A, R., Y, G., . . . RJ, A. (2026). Single-nuclei UPR profiling by flow cytometry reveals bortezomib resistance mechanisms in multiple myeloma. EMBO molecular medicine. https://doi.org/10.1038/s44321-026-00469-7
Chicago Style (17th ed.) CitationJP, Gigan, et al. "Single-nuclei UPR Profiling by Flow Cytometry Reveals Bortezomib Resistance Mechanisms in Multiple Myeloma." EMBO Molecular Medicine 2026. https://doi.org/10.1038/s44321-026-00469-7.
MLA (9th ed.) CitationJP, Gigan, et al. "Single-nuclei UPR Profiling by Flow Cytometry Reveals Bortezomib Resistance Mechanisms in Multiple Myeloma." EMBO Molecular Medicine, 2026, https://doi.org/10.1038/s44321-026-00469-7.
Warning: These citations may not always be 100% accurate.